Skip to main content

Day One Biopharmaceuticals, Inc.

DAWNDelisted Apr 23, 2026
Industry
Pharmaceutical Preparations
SEC CIK
0001845337

Day One Biopharmaceuticals, Inc. was delisted on Apr 23, 2026; its insiders filed their last Form 4 on Apr 27, 2026; 208 institutions reported holding it in 13F filings for Q1 2026, worth $1.85B in total; Soros Fund Management was the only superinvestor holding it.

Q2 2021 vs. Q1 2021

How the institutions holding Day One Biopharmaceuticals, Inc. changed between Q1 2021 and Q2 2021.

All holders in Q2 2021All holders in Q1 2021

13F holders of DAWN: Q1 2021 compared with Q2 2021
MeasureQ1 2021Q2 2021Change
Holders033+33
Shares017.7M+17.7M
Value$0$401.1M+$401.1M

New holders (33)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to DAWN in Q2 2021
InstitutionSharesValue% of portfolio
Ra Capital Management, L.P.4,965,588$113.1M1.81%
FMR LLC2,312,450$52.7M0.00%
Price T Rowe Associates Inc1,505,396$33.4M0.00%
Viking Global Investors LPSuperinvestorViking Global Investors1,341,396$30.5M0.09%
Janus Henderson Group PLC1,297,770$27.9M0.01%
Boxer Capital, LLC1,189,943$27.1M0.96%
BVF Inc918,975$20.9M0.78%
Deerfield Management Company, L.P. (Series C)818,980$18.6M0.33%
Perceptive Advisors LLC756,047$17.2M0.22%
Vanguard Group Inc619,384$14.1M0.00%
Franklin Resources Inc518,966$11.8M0.00%
Driehaus Capital Management LLC434,423$9.89M0.13%
Rock Springs Capital Management LP373,739$8.51M0.17%
Samsara BioCapital, LLC202,500$4.61M0.61%
HealthCor Management, L.P.103,717$2.36M0.10%
Alyeska Investment Group, L.P.103,200$2.35M0.03%
LMR Partners LLP50,000$1.14M0.02%
Marshall Wace North America L.P.41,147$937.0K0.00%
Logos Global Management LP37,069$844.0K0.07%
Geode Capital Management, LLC34,935$795.0K0.00%
Squarepoint Ops LLC18,927$431.0K0.00%
TD Asset Management Inc16,856$400.0K0.00%
Northern Trust Corp12,718$290.0K0.00%
Virtu Financial LLC12,497$285.0K0.03%
Goldman Sachs Group Inc11,594$264.0K0.00%
ExodusPoint Capital Management, LP9,372$213.0K0.00%
Maven Securities LTD9,000$210.0K0.02%
BlackRock Inc.4,372$99.0K0.00%
Morgan Stanley2,374$54.0K0.00%
Capital Analysts, LLC750$17.0K0.00%
Bank of America Corp700$16.0K0.00%
JPMorgan Chase & Co54$1.00K0.00%
Tower Research Capital LLC (TRC)10$00.00%

Sold out (0)

Institutions that held Day One Biopharmaceuticals, Inc. at the end of Q1 2021 and filed for Q2 2021 without it.

None.